This Medical Charity Made $3.3 Billion From a Single Pill

How the Cystic Fibrosis Foundation amassed a fortune—and upended medical research at the same time

Kalydeco, approved by the FDA in 2012, can treat cystic fibrosis in about 2,000 patients in the U.S. A year's supply costs more than $300,000. — Kalydeco, approved by the FDA in 2012, can treat cystic fibrosis in about 2,000 patients in the U.S. A year's supply costs more than $300,000.
Source: Vertex Pharmaceuticals

July 7, 2015 at 3:33 PM UTC

 

 

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Take our Survey

Before it's here, it's on the Bloomberg Terminal